Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BrainCo Helps Amputee Showcase Technology at WAIC 2025 2025-09-08 19:29
Remplir™ Study Delivers Compelling 81% Success Rate 2025-09-08 17:32
Sirnaomics Announces Strategic Equity Investment by Bloomage Biotech to Jointly Advance Next-Generation Life Science Pipelines 2025-09-08 12:15
Epigenic Therapeutics Announces Completion of $60 Million Series B Financing to Accelerate Clinical Development of Epigenetic Medicines 2025-09-08 10:00
Ivonescimab Plus Chemotherapy Demonstrates Consistent Global Benefit: HARMONi Data Update Shows OS HR=0.78, Nominal P=0.0332 2025-09-07 18:08
Senhwa Biosciences CX-5461 Secures NCI Support to Advance into MYC-Driven Lymphoma, Driving Cross-Cancer and Global Licensing Value 2025-09-05 16:46
Immunofoco Earns Spot on Forbes Asia 100 to Watch 2025 List for Leading New Wave in Solid Tumor Cell Therapy 2025-09-05 16:09
Alma, a Sisram Medical Company, Announces Strategic Collaboration with Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence 2025-09-04 22:00
Global Bio Conference 2025 kicks off in Seoul, charting biotech's future 2025-09-03 20:00
Acer Expands SpatialLabs Pro Ecosystem with Immersive 3D Capabilities Across Multiple Verticals 2025-09-03 17:40
Acer Medical Unveils aiMed Ahead of IFA 2025, Showcasing the Future of AI in Healthcare 2025-09-03 17:30
DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment 2025-09-03 10:52
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer's disease and Dementia Data 2025-09-02 21:00
Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program 2025-09-02 21:00
Desilo to Launch "HARVEST™," Encrypted Data Collaboration Platform for Healthcare, in December 2025-09-02 21:00
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform 2025-09-02 20:30
SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift 2025-09-02 19:00
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting 2025-09-02 18:00
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech's Discovery Insights 2025-09-02 17:52
Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy 2025-09-02 16:00
1 15 16 17 18 19 491